Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The Lancet. Oncology|November 6, 2010
New drugs for aggressive B-cell and T-cell lymphomasNiels Murawski, Michael Pfreundschuh
Expert Review of Anticancer Therapy|March 11, 2010
Unresolved issues in diffuse large B-cell lymphomasNiels Murawski, Carsten Zwick, Michael Pfreundschuh
Seminars in Hematology|March 31, 2010
Rituximab in high-grade lymphomaCarsten Zwick, Niels Murawski, Michael Pfreundschuh, et al.
International Journal of Cancer|May 1, 2009
A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUSKlaus-Dieter Preuss, Michael Pfreundschuh, Manfred Ahlgrimm, et al.
Plos One|February 12, 2014
Prevalence of anti-citrullinated protein antibodies (ACPA) in patients with diffuse large B-cell lymphoma (DLBCL): a case-control studyGunter Assmann, Klara Shihadeh, Viola Poeschel, et al.
International Journal of Cancer|February 14, 2015
CD4⁺ T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenström's macroglobulinemiaFrank Neumann, Michael Pfreundschuh, Klaus D Preuss, et al.
The Lancet. Oncology|September 22, 2009
Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control studySandra Grass, Klaus-Dieter Preuss, Manfred Ahlgrimm, et al.
Infectious Agents and Cancer|February 25, 2021
Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfallsDominic Kaddu-Mulindwa, Lorenz Thurner, Moritz Bewarder, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 8, 2020
Application and clinical impact of the RESIST-4 O.K.N.V. rapid diagnostic test for carbapenemase detection in blood cultures and clinical samplesSophie Roth, Fabian K Berger, Andreas Link, et al.
Human Gene Therapy|September 13, 2012
Mutated Ras-transfected, EBV-transformed lymphoblastoid cell lines as a model tumor vaccine for boosting T-cell responses against pancreatic cancer: a pilot trialBoris Kubuschok, Michael Pfreundschuh, Rainer Breit, et al.
Pageof 3